If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAura Egy Regulatory News (AURA)

Share Price Information for Aura Egy (AURA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.75
Bid: 9.50
Ask: 10.00
Change: 0.00 (0.00%)
Spread: 0.50 (5.263%)
Open: 9.75
High: 9.75
Low: 9.75
Prev. Close: 9.75
AURA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ASX Review

28 Oct 2020 08:05

RNS Number : 4618D
Aura Energy Limited
28 October 2020
 

 

28 October 2020

 

 

AURA ENERGY LIMITED

("Aura" or the "Company")

ASX Review

 

The review by the Australian Securities Exchange on recent share issues and the responses by the Company to matters raised by the ASX has now concluded. The Company believes in the interests of shareholders to agree with a directive by the ASX that it will seek pre-approval from shareholders for all share placements until 30 June 2022.

 

The ASX determined that a contract definition in the Lind Convertible Note that gives rise to the sub-$9 million capitalisation should have been disclosed to shareholders prior to the cleansing statement, dated 13 March 2020. Aura Energy continues to maintain that disclosure of that particular clause at the initial release was not necessary as it was one of many prescribed adverse conditions, and it was not close to being activated. However, as a result the ASX determined Aura Energy exceeded its placement capacity based on Listing Rule 7.1.

 

The ASX has advised that the Company is entitled to make share issues under ASX LR 7.2 without shareholder approval. This listing rules permits, amongst other things, Aura Energy to raise monies by way of rights issues and share purchase plans in the ordinary manner.

 

The board of directors believe it is in the interests of all shareholders that the matters raised by the ASX be resolved however highlights that the board of directors entered into the Convertible Security Facility Agreement as it had a fiduciary obligation to shareholders to ensure that the tenements of the Company were in good standing and that the Company was a going concern. The Convertible Security Facility Agreement ensured this outcome as the Company had no other equity raising opportunities available by the end of April 2019.

 

Additional points:

 

· ASX determined AEE exceeded its capacity to issue equity by 781,791,184 equity securities under Listing Rule 7.1

· AEE is pursuant to Listing Rule 7.1A not entitled to an additional 10% placement capacity until at least its annual general meeting after 30 June 2022

· Ratification by security holders of the securities which exceeded capacity under LR 7.1 cannot be used to refresh AEE's capacity

· AEE was not entitled to rely on the Class Waiver as it had already exceeded its capacity under Listing Rule 7.1.

 

 

For further information please contact:

 

Aura Energy Limited

Peter Reeve (Executive Chairman)

 

SP Angel Corporate Finance LLP

(Nominated Advisor and Joint Broker)

Ewan Leggat

Caroline Rowe

 

WH Ireland Limited

(Joint Broker)

Adrian Hadden

James Sinclair-Ford

 

 

 

Yellow Jersey PR Limited

Felicity Winkles

Joe Burgess

 

Telephone: +61 (3) 9516 6500

info@auraenergy.com.au

 

Telephone: +44 (0) 203 470 0470

 

 

 

 

 

Telephone: +44 (0) 207 220 1666

 

 

 

 

 

Telephone: +44 (0) 7769 325 254

 

 

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCMPBPTMTMTMJM
Date   Source Headline
31st Mar 20239:00 amRNSPrice Monitoring Extension
31st Mar 20238:17 amRNSASX Trading Halt
31st Mar 20238:01 amRNSTotal Voting Rights
29th Mar 20237:01 amRNSEnhanced Feasibility Study Investor Webinar
29th Mar 20237:00 amRNSEnhanced Feasibility Study - Tiris Uranium Project
24th Mar 20237:00 amRNSHolding(s) in Company
23rd Mar 20237:03 amRNSHolding(s) in Company
20th Mar 20237:55 amRNSIssue of Equity
16th Mar 20238:09 amRNSHalf-year Report
10th Mar 20237:00 amRNSRelease of Shares from Voluntary Escrow
6th Mar 20237:00 amRNSIssue of Equity
28th Feb 20237:00 amRNSTotal Voting Rights
20th Feb 20237:00 amRNSIssue of Equity
14th Feb 20237:00 amRNSMajor Resource Upgrade at Aura’s Tiris Project
10th Feb 20237:00 amRNSHolding(s) in Company
10th Feb 20237:00 amRNSHolding(s) in Company
3rd Feb 20237:00 amRNSIssue of Equity
1st Feb 20237:00 amRNSTransformational Agreements finalised for Tiris
31st Jan 20237:45 amRNSTotal Voting Rights
31st Jan 20237:18 amRNSQuarterly Report for the Period Ending 31 Dec 2022
23rd Jan 20239:05 amRNSSecond Price Monitoring Extn
23rd Jan 20239:00 amRNSPrice Monitoring Extension
13th Jan 20237:00 amRNSIssue of Equity
12th Jan 20237:24 amRNSDirector Dealing
30th Dec 20227:00 amRNSTotal Voting Rights
22nd Dec 20228:28 amRNSAppendix 3Y
21st Dec 20227:00 amRNSAdmission of Loan Funded Shares
7th Dec 20227:34 amRNSIssue of Equity
6th Dec 20227:51 amRNSTiris Project Uranium Product
2nd Dec 20227:25 amRNSHolding(s) in Company
1st Dec 20228:18 amRNSHolding(s) in Company
30th Nov 20227:00 amRNSTotal Voting Rights
29th Nov 20229:21 amRNSResults of Annual General Meeting
29th Nov 20227:00 amRNSInvestor Presentation
18th Nov 20227:44 amRNSInvestor Presentation
18th Nov 20227:41 amRNSIssue of Equity
4th Nov 20227:00 amRNSIssue of Equity
31st Oct 20227:02 amRNSTotal Voting Rights
31st Oct 20227:01 amRNSNotice of Annual General Meeting
31st Oct 20227:00 amRNSQuarterly Report for the Period Ending 30 Sept 22
27th Oct 20229:10 amRNSHolding(s) in Company
25th Oct 20228:58 amRNSHolding(s) in Company
20th Oct 20228:48 amRNSNew Investor Presentation
19th Oct 20228:25 amRNSAura Continues to Advance Tiris Uranium Project
18th Oct 20227:00 amRNSAppendix 3X
14th Oct 20227:00 amRNSIssue of Equity
6th Oct 202210:04 amRNSRelated Party Transaction
4th Oct 20227:04 amRNSIssue of Equity
4th Oct 20227:00 amRNSTotal Voting Rights
30th Sep 202211:09 amRNS2022 Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.